Israel’s Teva has signed an agreement with Galena Biopharma to take its NeuVax early stage breast cancer treatment through its last stage trials and through to sales. Israel will be the location of at least four clinical trial sites for the NeuVax Phase III trials.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000803689
Final phase for breast cancer treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.